Genetic Technologies has signed a settlement and license agreement with Eurofins STA Laboratories of Longmont, Colorado, USA.
Subscribe to our email newsletter
As per the agreement, Eurofins STA will gain non-exclusive rights to a number of GTG patents relating to its non-coding DNA technology.
The precise commercial terms of the agreement are covered by formal confidentiality provisions and cannot be disclosed, the companies said.
Eurofins STA was a counterparty to the third formal patent assertion suit filed by Genetic Technologies against ten companies in the US District Court for the District of Colorado.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.